HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.

Abstract
ABO incompatible living donor renal transplantation (ABOi) can achieve outcomes comparable to ABO compatible transplantation (ABOc). However, with the exception of blood group A2 kidneys transplanted into recipients with low titer anti-A antibody, regimens generally include antibody removal, intensified immunosuppression and splenectomy or rituximab. We now report a series of 20 successful renal transplants across a range of blood group incompatibilities using conventional immunosuppression alone in recipients with low baseline anti-blood group antibody (ABGAb) titers. Incompatibilities were A1 to O (3), A1 to B (2), A2 to O (2), AB to A (2), AB to B (1), B to A1 (9), B to O (1); titers 1:1 to 1:16 by Ortho. At 36 months, patient and graft survival are 100%. Antibody-mediated rejection (AbMR) occurred in one patient with thrombophilia and low level donor-specific anti-HLA antibody. Four patients experienced cellular rejection (two subclinical), which responded to oral prednisolone. This series demonstrates that selected patients with low titer ABGAb can undergo ABOi with standard immunosuppression alone, suggesting baseline titer as a reliable predictor of AbMR. This reduces morbidity and cost of ABOi for patients with low titer ABGAb and increases the possibility of ABOi from deceased donors.
AuthorsR Masterson, P Hughes, R G Walker, C Hogan, M Haeusler, A R Robertson, R Millar, N Suh, S J Cohney
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 14 Issue 12 Pg. 2807-13 (Dec 2014) ISSN: 1600-6143 [Electronic] United States
PMID25389083 (Publication Type: Comparative Study, Journal Article, Observational Study)
Copyright© Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.
Chemical References
  • ABO Blood-Group System
  • Immunosuppressive Agents
Topics
  • ABO Blood-Group System (immunology)
  • Adult
  • Blood Group Incompatibility (immunology)
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Graft Rejection (drug therapy, immunology)
  • Graft Survival
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents (therapeutic use)
  • Kidney Failure, Chronic (surgery)
  • Kidney Function Tests
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Plasmapheresis
  • Postoperative Complications
  • Prognosis
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: